|
"lu sn"的相关文件
显示项目 1-29 / 29 (共1页)
1
每页显示[10|25|50]项目
| 國家衛生研究院 |
2025-08-06 |
Secular trends and survival impact of high proportion of curative treatments for hepatocellular carcinoma in Taiwan, 2011-2019
|
Kee, KM;Chen, CH;Liu, TW;Huang, YH;Hu, JT;Chau, GY;Chen, KH;Chiang, CJ;Lin, CC;Hung, CF;Wang, TE;Huang, SF;Ku, HY;Huang, BS;Ch'ang, HJ;Tseng, HP;Lu, SN |
| 國家衛生研究院 |
2022-12-31 |
Secular trends of clinical characteristics and survival of hepatocellular carcinoma in Taiwan from 2011 to 2019
|
Kee, KM;Chen, CH;Hu, JT;Huang, YH;Wang, TE;Chau, GY;Chen, KH;Chen, YL;Lin, CC;Hung, CF;Huang, SF;Liu, TW;Ku, HY;Huang, BS;Wang, YP;Tseng, HP;Chiang, CJ;Lu, SN |
| 國家衛生研究院 |
2022-01-14 |
Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B
|
Hu, HH;Jeng, WJ;Pan, MH;Luo, WS;Chang, CL;Huang, YT;Su, CY;Chiang, CT;Jen, CL;Chien, YC;Lu, SN;Wang, LY;Huang, LR;Lee, MH;Liu, J;Nguyen, MH;Chen, CJ;Yang, HI |
| 國家衛生研究院 |
2021-07-15 |
How may ramucirumab help improve treatment outcome for patients with gastrointestinal cancers?
|
Chen, MH;Lu, SN;Chen, CH;Lin, PC;Jiang, JK;D'Yachkova, Y;Lukanowski, M;Cheng, R;Chen, LT |
| 國家衛生研究院 |
2020-03 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: A TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Chen, LT;Martinelli, E;Cheng, AL;Pentheroudakis, G;Qin, S;Bhattacharyya, GS;Ikeda, M;Lim, HY;Ho, GF;Choo, SP;Ren, Z;Malhotra, H;Ueno, M;Ryoo, BY;Kiang, TC;Tai, D;Vogel, A;Cervantes, A;Lu, SN;Yen, CJ;Huang, YH;Chen, SC;Hsu, C;Shen, YC;Tabernero, J;Yen, Y;Hsu, CH;Yoshino, T;Douillard, JY |
| 國家衛生研究院 |
2018-04-05 |
ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
|
Abou-Alfa, G;Qin, S;Ryoo, BY;Lu, SN;Yen, CJ;Feng, YH;Lim, HY;Izzo, F;Colombo, M;Sarker, D;Bolondi, L;Vaccaro, G;Harris, WP;Chen, Z;Hubner, RA;Meyer, T;Sun, W;Harding, JJ;Hollywood, EM;Ma, J;Wan, PJ;Ly, M;Bomalaski, J;Johnston, A;Lin, CC;Chao, Y;Chen, LT |
| 國家衛生研究院 |
2017-10 |
Serum soluble programmed cell death 1 level as a key predictor for spontaneous functional cure of chronic hepatitis B patients
|
Hu, HH;Pan, MH;Luo, WS;Chang, CL;Jeng, RWJ;Huang, YT;Su, CY;Chiang, CT;Jen, CL;Lu, SN;Wang, LY;Huang, LR;Shih, CH;Chen, CJ;Yang, HI |
| 國家衛生研究院 |
2016-05 |
Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC)
|
Abou-Alfa, GK;Qin, SK;Ryoo, BY;Lu, SN;Yen, CJ;Feng, YH;Lim, HY;Izzo, F;Colombo, M;Sarker, D;Bolondi, L;Vaccaro, GM;Harris, WP;Chen, ZD;Hubner, R;Meyer, T;Bomalaski, JS;Lin, CC;Chao, Y;Chen, LT |
| 中國醫藥大學 |
2014-03 |
A double-blind randomized controlled study to evaluate the efficacy of low-dose oral interferon-alpha in preventing hepatitis C relapse
|
(Lee CM);(Chen CY);(Chien RN);(Tseng KC);彭成元(Cheng-Yuan Peng);(Tung SY);(Fang YJ);(Huang YH);(Lu SN);(Hung CH);(Tsai TJ);(Fang CC);(Hsu CW);(Yeh CT)* |
| 中國醫藥大學 |
2013-03 |
Prediction models of long-term cirrhosis and HCC risk in chronic hepatitis B patients: Risk scores integrating host and virus profiles
|
(Lee MH);楊懷壹(Hwai-I Yang);(Liu J);(Batrla-Utermann R);(Jen CL);(Iloeje UH);(Lu SN);(You SL);(Wang LY);(Chen CJ)* |
| 中國醫藥大學 |
2012-12 |
A Predictive Scoring System for the Seroclearance of HBsAg in HBeAg-seronegative Chronic Hepatitis B Patients with Genotype B or C Infection
|
(Liu J);(Lee MH);(Batrla-Utermann R);(Jen CL);(Iloeje UH);(Lu SN);(Wang LY);(You SL);(Hsiao CK);楊懷壹(Hwai-I Yang);(Chen CJ)* |
| 中國醫藥大學 |
2012-08 |
Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study
|
(Lee MH);楊懷壹(Hwai-I Yang);(Lu SN);(Jen CL);(You SL);(Wang LY);(Wang CH);(Chen WJ);(Chen CJ)* |
| 中國醫藥大學 |
2012-04 |
Association between obesity, hypertriglyceridemia and low hepatitis B viral load
|
(Chiang CH);楊懷壹(Hwai-I Yang);(Jen CL);(Lu SN);(Wang LY);(You SL);(Su J);(Iloeje UH);(Chen CJ)* |
| 臺北醫學大學 |
2012 |
A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy
|
Chang, KC;Hung, CH;Lu, SN;Wang, JH;LEE, CM;Chen, CH;Yen, MF;Lin, SC;Yen, YH;Tsai, MC;Tseng, PL;Hu, TH |
| 中國醫藥大學 |
2011-11-08 |
Single nucleotide polymorphisms associatiedwith elevated serum viral load of hepatitis B virus in patients with chronic hepatitis B: A genome-wide assoiation study in Taiwan
|
(Lee MH);楊懷壹(Hwai-I Yang);(Lin YJ);(Jen CL);(Lu SN);(Yuan Y)(Litalian ;G);(Chen CJ) |
| 中國醫藥大學 |
2011-09 |
Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C
|
(Huang YT);(Jen CL);楊懷壹(Hwai-I Yang);(Lee MH);(Su J);(Lu SN);(Iloeje UH);(Chen CJ)* |
| 中國醫藥大學 |
2011-06 |
Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma
|
(Chen CF);(Lee WC);楊懷壹(Hwai-I Yang);(Chang HC);(Jen CL);(Iloeje UH);(Su J);(Hsiao CK);(Wang LY);(You SL);(Lu SN);(Chen CJ)* |
| 國家衛生研究院 |
2010-09 |
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
|
Yang, TS;Lu, SN;Chao, Y;Sheen, IS;Lin, CC;Wang, TE;Chen, SC;Wang, JH;Liao, LY;Thomson, JA;Wang-Peng, J;Chen, PJ;Chen, LT |
| 高雄醫學大學 |
2010 |
流行地區的B、C型肝炎與慢行腎臟病相關性--一個橫斷性研究
|
李佳蓉;林明彥;楊奕馨;盧勝男;陳鴻鈞;黃尚志; Lee JJ;Lin MY;Yang YH;Lu SN;Chen HC;Hwang SJ |
| 國立臺灣大學 |
2008-12 |
Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
|
Yang, WI; Yeh; SH, Chen, PJ; Iloeje, UH; Jen, CL; Su, J; Wang, LY; Lu, SN; You, SL; Chen, DS; Liaw, YF; Chen, CJ |
| 國立臺灣大學 |
2008-11 |
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: A follow-up study in Taiwan
|
Chen, CL; Yang, HI; Yang, WS; Liu, CJ; Chen, PJ; You, SL; Wang, LY; Sun, CA; Lu, SN; Chen, DS; Chen, CJ |
| 國立臺灣大學 |
2008-08 |
Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
|
Yang, HI; Yeh, SH; Chen, PJ; Iloeje, UH; Jen, CL; Su, J; Wang, LY; Lu, SN; You, SL; Chen, DS; Liaw, YF; Chen, CJ |
| 國立臺灣大學 |
2008-07 |
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.
|
Chen, CL; Yang, HI; Yang, WS; Liu, CJ; Chen, PJ; You, SL; Wang, LY; Sun, CA; Lu, SN; Chen, DS; Chen, CJ. |
| 國立臺灣大學 |
2006-07 |
Village distribution and geographic variations of the prevalence of chronic hepatitis B, C and hypertransaminemia: an analysis of adult health examinations in 520 village of Tainan county, Taiwan
|
Chen, PF; Kee, KM; Chen, YD; Tsai, LS; Shih, LY; Lin, LC; Chen, THH; Lu, SN |
| 高雄醫學大學 |
2006 |
A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide; multicentre study in Taiwan.
|
余明隆;林錫明;莊萬龍;戴嘉言;王景弘;盧勝男;沈一嫻;張文宇;李全謀;廖運範 ; Yu ML;Lin SM;Chuang WL;Dai CY;Wang JH;Lu SN;Sheen IS;Chang WY;Lee CM;Liaw YF |
| 高雄醫學大學 |
2005 |
Lupus 病人之EBV VCA IgA 高盛行率
|
陳忠仁;林貴香;林世昌;蔡文展;葉宏明;章順仁;盧勝男;劉宏文 ; Chen CJ;Lin KH;Lin SC;Tsai WC;Yen JH;Chang SJ;Lu SN;Liu HW |
| 國立臺灣大學 |
2002-07 |
Ultrasound screening and risk factor for death from hepatocellular carcinoma in a high risk group in Taiwan
|
Chen, THH; Chen, CJ; Yen, MF; Lu, SN; Sun, CA; Huang, GT; Yang, PM; Lee, HS; Duffy, SW |
| 高雄醫學大學 |
1996 |
台灣南部地區慢性C型肝炎病患C型肝炎毒基因型
|
余明隆;莊萬龍;盧勝男;陳信成;王景弘;林子堯;謝明裕;王良彥;張文宇 ; Yu ML;Chuang WL;Lu SN;Chen SC;Wang JH;Lin ZY;Hsieh MY;Wang LY;Chang WY |
| 高雄醫學大學 |
1996 |
High seroprevalence of IgG against Helicobacter pylori among endoscopists in Taiwan.
|
蘇育正;王文明;陳立宗;陳章義;盧勝男;詹昌明 ; Su YC;Wang WM;Chen LT;Chiang W;Chen CY;Lu SN;Jan CM |
显示项目 1-29 / 29 (共1页)
1
每页显示[10|25|50]项目
|
